BerandaIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
$39,08
Setelah Jam Perdagangan Normal:(0,00%)0,00
$39,08
Tutup: 10 Mei, 17.20.00 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$39,47
Rentang hari
$38,80 - $39,78
Rentang tahun
$34,99 - $54,44
Kapitalisasi pasar
5,70Â M USD
Volume Rata-Rata
976,83Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Berita terpopuler
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2023info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 324,50Â jt | 113,65% |
Biaya operasional | 51,01Â jt | 6,38% |
Laba bersih | -9,26Â jt | 82,33% |
Margin laba bersih | -2,85 | 91,74% |
Penghasilan per saham | 0,12 | 109,98% |
EBITDA | 18,74Â jt | 109,26% |
Tarif pajak efektif | -234,77% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2023info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,34Â M | 17,03% |
Total aset | 2,99Â M | 18,00% |
Total liabilitas | 2,60Â M | 32,76% |
Total ekuitas | 386,69 jt | — |
Saham yang beredar | 145,75 jt | — |
Harga terhadap reservasi | 14,73 | — |
Tingkat pengembalian aset | 1,31% | — |
Pengembalian modal | 1,68% | — |
Arus Kas
Perubahan bersih tunai
| (USD) | Des 2023info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -9,26Â jt | 82,33% |
Kas dari operasi | 32,86Â jt | 116,42% |
Tunai dari investasi | -26,71Â jt | -112,59% |
Tunai dari pembiayaan | 40,72Â jt | 179,82% |
Perubahan bersih tunai | 47,21Â jt | 222,55% |
Arus kas bebas | 58,22Â jt | 149,63% |
Tentang
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza, Tegsedi, and Waylivra and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.
The company was named Isis Pharmaceuticals until December 2015. Wikipedia
Didirikan
1989
Kantor pusat
Situs
Karyawan
927
